Growth Equity Opportunities 18 VGE, LLC

13D and 13G Filings

13D/G filings: 13D on 3 securities
CIK: 0001917895
All SEC filings: View on sec.gov

Issuer	Symbol	CUSIP	% of Class	Shares	Form	Filed
Celcuity Inc. 13D/A Amendment 4 CELC · 15102K100	CELC	15102K100	4.9%	2,285,561	13D/A Amendment 4	3/9/2026 Event 3/5/2026
Growth Equity Opportunities 18 VGE, LLC			4.9%	2,285,561
NEA 18 Venture Growth Equity, L.P.			4.9%	2,285,561
NEA Partners 18 VGE, L.P.			4.9%	2,285,561
Nea 18 Vge GP, LLC			4.9%	2,285,561
Ali Behbahani			4.9%	2,285,561
Carmen Chang			4.9%	2,285,561
Anthony A. Florence, Jr.			4.9%	2,285,561
Mohamad H. Makhzoumi			4.9%	2,285,561
Edward T. Mathers			4.9%	2,285,561
Scott D. Sandell			4.9%	2,285,561
Paul Walker			4.9%	2,285,561
Rick Yang			4.9%	2,285,561
Gossamer Bio, Inc. 13D/A Amendment 1 GOSS · 38341P102	GOSS	38341P102	1.7%	4,065,134	13D/A Amendment 1	2/24/2026 Event 2/23/2026
Growth Equity Opportunities 18 VGE, LLC			1.7%	4,065,134
NEA 18 Venture Growth Equity, L.P.			1.7%	4,065,134
NEA Partners 18 VGE, L.P.			1.7%	4,065,134
Nea 18 Vge GP, LLC			1.7%	4,065,134
Ali Behbahani			1.7%	4,065,134
Carmen Chang			1.7%	4,065,134
Anthony A. Florence, Jr.			1.7%	4,065,134
Mohamad H. Makhzoumi			1.7%	4,065,134
Edward T. Mathers			1.7%	4,065,134
Scott D. Sandell			1.7%	4,065,134
Paul Walker			1.7%	4,065,134
Rick Yang			1.7%	4,065,134
Celcuity Inc. 13D/A Amendment 3 CELC · 15102K100	CELC	15102K100	6.3%	2,910,561	13D/A Amendment 3	1/16/2026 Event 1/14/2026
Growth Equity Opportunities 18 VGE, LLC			6.3%	2,910,561
NEA 18 Venture Growth Equity, L.P.			6.3%	2,910,561
NEA Partners 18 VGE, L.P.			6.3%	2,910,561
Nea 18 Vge GP, LLC			6.3%	2,910,561
Ali Behbahani			6.3%	2,910,561
Carmen Chang			6.3%	2,910,561
Anthony A. Florence, Jr.			6.3%	2,910,561
Mohamad H. Makhzoumi			6.3%	2,910,561
Edward T. Mathers			6.3%	2,910,561
Scott D. Sandell			6.3%	2,910,561
Paul Walker			6.3%	2,910,561
Rick Yang			6.3%	2,910,561
X4 Pharmaceuticals, Inc. 13D/A Amendment 4 XFOR · 98420X202	XFOR	98420X202	6.2%	5,057,610	13D/A Amendment 4	10/29/2025 Event 10/27/2025
Growth Equity Opportunities 18 VGE, LLC			6.2%	5,057,610
NEA 18 Venture Growth Equity, L.P.			6.2%	5,057,610
NEA Partners 18 VGE, L.P.			6.2%	5,057,610
Nea 18 Vge GP, LLC			6.2%	5,057,610
Ali Behbahani			6.2%	5,057,610
Carmen Chang			6.2%	5,057,610
Anthony A. Florence, Jr.			6.2%	5,057,610
Mohamad H. Makhzoumi			6.2%	5,057,610
Edward T. Mathers			6.2%	5,057,610
Scott D. Sandell			6.2%	5,057,610
Paul Walker			6.2%	5,057,610
Rick Yang			6.2%	5,057,610
Celcuity Inc. 13D/A Amendment 2 CELC · 15102K100	CELC	15102K100	8.1%	3,535,561	13D/A Amendment 2	8/18/2025 Event 8/14/2025
Growth Equity Opportunities 18 VGE, LLC			8.1%	3,535,561
NEA 18 Venture Growth Equity, L.P.			8.1%	3,535,561
NEA Partners 18 VGE, L.P.			8.1%	3,535,561
Nea 18 Vge GP, LLC			8.1%	3,535,561
Ali Behbahani			8.1%	3,535,561
Carmen Chang			8.1%	3,535,561
Anthony A. Florence, Jr.			8.1%	3,535,561
Liza Landsman			0%	0
Mohamad H. Makhzoumi			8.1%	3,535,561
Edward T. Mathers			8.1%	3,535,561
Scott D. Sandell			8.1%	3,535,561
Peter W. Sonsini			0%	0
Paul Walker			8.1%	3,535,561
Rick Yang			8.1%	3,535,561
X4 Pharmaceuticals, Inc. 13D/A Amendment 3 XFOR · 98420X202	XFOR	98420X202	10.0%	2,243,658	13D/A Amendment 3	8/15/2025 Event 8/13/2025
Growth Equity Opportunities 18 VGE, LLC			10.0%	2,243,658
NEA 18 Venture Growth Equity, L.P.			10.0%	2,243,658
NEA Partners 18 VGE, L.P.			10.0%	2,243,658
Nea 18 Vge GP, LLC			10.0%	2,243,658
Ali Behbahani			10.0%	2,243,658
Carmen Chang			10.0%	2,243,658
Anthony A. Florence, Jr.			10.0%	2,243,658
Mohamad H. Makhzoumi			10.0%	2,243,658
Edward T. Mathers			10.0%	2,243,658
Scott D. Sandell			10.0%	2,243,658
Paul Walker			10.0%	2,243,658
Rick Yang			10.0%	2,243,658

Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.